Alexza Pharmaceuticals, Inc.

(NASDAQ:ALXA)

1.45

-0.15 (-9.38%)

Dec 04 - Close

Open
1.56
High
1.66
Low
1.43
Vol.
137.93K
Mkt Cap
52.51M
52Wk High
8.63
52Wk Low
1.16
Avg. Vol.
86.90K
P/E (Trailing)
-0.81
Beta
1.43
Short %
5.50%
Div. Yield
—

After-Hours 1.48 +0.03 (2.07%) Thu, 4 Dec 2008 7:40 PM

Company Profile

Alexza Pharmaceuticals, Inc.

2091 Stierlin Court

Mountain View, CA 94043

United States - Map

Phone: (650) 944-7000

Fax: (650) 944-7999

Website: www.alexza.com

State of incorporation: Delaware

CEO: Thomas B. King

Employees: 144

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

Dev drugs for acute & intermittent conditions

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recent news for ALXA

Recent opinions on ALXA

No recent Opinions for ALXA

No members own ALXA

Member sentiment: Neutral